Immunotherapy drug strengthens head, neck cancer treatment: Study

A recently conducted clinical trial by the University of Cincinnati showed that by adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features has increased.

Related Keywords

United States ,American , ,Neck Center ,Uc College Of Medicine ,Division Of Hematology Oncology ,University Of Cincinnati ,American Association For Cancer Research ,Harvard University ,Uc Health ,Clinical Cancer Research ,American Association ,Trisha Wise Draper ,Cincinnati Cancer Center Clinical Trials Office ,